----item----
version: 1
id: {A116AE34-14E0-45A6-A17D-DB5289621E66}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/08/19/Valeant Adds Robert Hale To Board
parent: {7FE23635-8382-43A3-A553-ABD9FDB27BAD}
name: Valeant Adds Robert Hale To Board
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: 95ff225a-4ead-4d92-9367-fa2230b02031

----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{3FA7743D-5DAB-49A3-B30D-DF5079ADB082}
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 33

Valeant Adds Robert Hale To Board
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 33

Valeant Adds Robert Hale To Board
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 936

<p>Valeant Pharmaceuticals International, Inc. has appointed D. Robert Hale to its board of directors and in parallel announced the resignation of director Jeffrey W. Ubben. </p><p>Hale is currently a partner of ValueAct Capital, an investment firm based in San Francisco with over $20bn under management, which owns 4% of the outstanding stock of Valeant and has been a shareholder in the company since 2006. As a Partner and member of the investment team of ValueAct Capital, Hale has worked closely with the board and management team of Valeant since January 2011. He will be the fourth partner of ValueAct Capital to serve on the Valeant board, following Mason Morfit, Brandon Boze, and Jeff Ubben. </p><p>Meanwhile, though Ubben will no longer serve as a director of Valeant, he stated: "I look forward to working with [Valeant chair and CEO] Mike Pearson and the Valeant team as an interested shareholder on an ongoing basis."</p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 178

<p>Valeant Pharmaceuticals International, Inc. has appointed D. Robert Hale to its board of directors and in parallel announced the resignation of director Jeffrey W. Ubben. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 33

Valeant Adds Robert Hale To Board
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150819T052527
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150819T052527
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150819T052527
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC029594
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 33

Valeant Adds Robert Hale To Board
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{090E9A04-9B4B-4986-8BAF-06A6B07B978D}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 4

News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

360017
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042440Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

95ff225a-4ead-4d92-9367-fa2230b02031
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042440Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
